GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Policy Acquisition Expense

Kineta (STU:J75) Policy Acquisition Expense


View and export this data going back to 2017. Start your Free Trial

What is Kineta Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Kineta (STU:J75) Business Description

Industry
Traded in Other Exchanges
Address
219 Terry Avenue North, Suite 300, Seattle, WA, USA, 98109
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.